Dynamic alterations of plasma cell free DNA in response to chemotherapy in children with neuroblastoma

BACKGROUND: To improve cure rates for neuroblastoma (NB), it is important and necessary to evaluate therapy response. Our investigation focuses on using plasma cell free DNA (cfDNA) as a biomarker to determine tumor burden and minimal residual disease (MRD) of NB patients during chemotherapy. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Yan, Wang, Lijun, Wang, Xisi, Yue, Zhixia, Xing, Tianyu, Zhao, Wen, Zhao, Qian, Duan, Chao, Huang, Cheng, Han, Yi, Qiu, Lihua, Cheng, Xianfeng, Liu, Yi, Ma, Xiaoli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488154/
https://www.ncbi.nlm.nih.gov/pubmed/30793512
http://dx.doi.org/10.1002/cam4.2045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488154/
https://www.ncbi.nlm.nih.gov/pubmed/30793512
http://dx.doi.org/10.1002/cam4.2045

Ejemplares similares